MAP PHARMACEUTICALS, INC. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
MAP PHARMACEUTICALS, INC. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $316.26 million as of 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2012-11-06
- 2012-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $316.26M.
- 2012-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $303.64M.
- 2012-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $290.35M.
- 2011-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $272.50M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) as first filed |
|---|---|---|
| 2012-09-30 | $316.26M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $303.64M 10-Q · filed 2012-07-27 | |
| 2012-03-31 | $290.35M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $272.50M 10-Q · filed 2012-11-06 | |
| 2011-09-30 | $258.68M 10-Q/A · filed 2012-03-30 | $219.38M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $266.87M 10-Q/A · filed 2012-03-30 | $230.59M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $239.56M 10-K · filed 2012-03-30 |